Literature DB >> 17133656

Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization.

Peijun Chen1, Helen C Kales, Daniel Weintraub, Frederic C Blow, Lan Jiang, Rosalinda V Ignacio, Alan M Mellow.   

Abstract

OBJECTIVE: To determine the frequency of depression in Parkinson's disease (PD) in routine clinical care, and to examine its association with co-morbid psychiatric and medical conditions and healthcare utilization.
METHODS: Depression diagnoses and healthcare utilization data for all male veterans with PD age 55 or older seen in fiscal year 2002 (n = 41,162) were analyzed using Department of Veterans Affairs (VA) national databases. Frequencies of co-morbid disorders and healthcare utilization were determined for depressed and non-depressed patients; associations with depression were examined using multivariate logistic regression models.
RESULTS: A depression diagnosis was recorded for 18.5% of PD patients, including major depression in 3.9%. Depression decreased in frequency and severity with increasing age. In multivariate logistic regression models, depressed patients had significantly greater psychiatric and medical co-morbidity, including dementia, psychosis, stroke, congestive heart failure, diabetes, and chronic obstructive pulmonary disease than non-depressed patients (all p < 0.01). Depressed PD patients were also significantly more likely to have medical (OR = 1.34, 95% CI = 1.25-1.44) and psychiatric hospitalizations (OR = 2.14, 95% CI = 1.83-2.51), and had more outpatient visits (p < 0.01), than non-depressed PD patients in adjusted models.
CONCLUSION: Depression in PD in non-tertiary care settings may not be as common or as severe as that seen in specialty care, though these findings also may reflect under-recognition or diagnostic imprecision. The occurrence of depression in PD is associated with greater psychiatric and medical co-morbidity, and greater healthcare utilization. These findings suggest that screening for depression in PD is important and should be embedded in a comprehensive psychiatric, neuropsychological, and medical evaluation. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17133656      PMCID: PMC2000482          DOI: 10.1002/gps.1712

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  30 in total

Review 1.  Depression and Parkinson's disease: a review.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

2.  A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease.

Authors:  S E Starkstein; H S Mayberg; R Leiguarda; T J Preziosi; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

3.  Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

Authors:  Daniel Weintraub; Paul J Moberg; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Am Geriatr Soc       Date:  2004-05       Impact factor: 5.562

4.  The frequency and associated risk factors for dementia in patients with Parkinson's disease.

Authors:  K Marder; M X Tang; L Cote; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1995-07

5.  Mortality in Parkinson's disease and its association with dementia and depression.

Authors:  T A Hughes; H F Ross; R H S Mindham; E G S Spokes
Journal:  Acta Neurol Scand       Date:  2004-08       Impact factor: 3.209

6.  Psychiatric comorbidities in patients with Parkinson disease and psychosis.

Authors:  L Marsh; J R Williams; M Rocco; S Grill; C Munro; T M Dawson
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  Benzodiazepine use among depressed patients treated in mental health settings.

Authors:  Marcia Valenstein; Kiran Khanujua Taylor; Karen Austin; Helen C Kales; John F McCarthy; Frederic C Blow
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

8.  An estimate of the incidence of depression in idiopathic Parkinson's disease.

Authors:  G Dooneief; E Mirabello; K Bell; K Marder; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1992-03

9.  Depression in Parkinson's disease.

Authors:  P Hantz; G Caradoc-Davies; T Caradoc-Davies; M Weatherall; G Dixon
Journal:  Am J Psychiatry       Date:  1994-07       Impact factor: 18.112

10.  Coexisting dementia and depression in Parkinson's disease.

Authors:  M Sano; Y Stern; J Williams; L Coté; R Rosenstein; R Mayeux
Journal:  Arch Neurol       Date:  1989-12
View more
  8 in total

1.  Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.

Authors:  Daniel Weintraub; Peijun Chen; Rosalinda V Ignacio; Eugenia Mamikonyan; Helen C Kales
Journal:  Arch Neurol       Date:  2011-07

2.  Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Kevin R Krull; Robert D Annett; Zhenyu Pan; Kirsten K Ness; Paul C Nathan; Deo Kumar Srivastava; Marilyn Stovall; Leslie L Robison; Melissa M Hudson
Journal:  Eur J Cancer       Date:  2011-03-31       Impact factor: 9.162

3.  Hospital care for mental health and substance abuse conditions in Parkinson's disease.

Authors:  Allison W Willis; Dylan P Thibault; Peter N Schmidt; E Ray Dorsey; Daniel Weintraub
Journal:  Mov Disord       Date:  2016-12       Impact factor: 10.338

4.  Morbidities in rapid eye movement sleep behavior disorder.

Authors:  Poul Jennum; Geert Mayer; Yo-El Ju; Ron Postuma
Journal:  Sleep Med       Date:  2013-01-29       Impact factor: 3.492

5.  Suicidal and death ideation in Parkinson's disease.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Gregory K Brown; Tom Ten Have; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

6.  Severe mental illness and health service utilisation for nonpsychiatric medical disorders: A systematic review and meta-analysis.

Authors:  Amy Ronaldson; Lotte Elton; Simone Jayakumar; Anna Jieman; Kristoffer Halvorsrud; Kamaldeep Bhui
Journal:  PLoS Med       Date:  2020-09-14       Impact factor: 11.069

Review 7.  Emotional dysfunction in Parkinson's disease.

Authors:  Lee X Blonder; John T Slevin
Journal:  Behav Neurol       Date:  2011       Impact factor: 3.342

8.  Understanding health care needs among Veterans with Parkinson's disease: A survey study.

Authors:  Megan Feeney; John Duda; Amie Hiller; Jay Phillips; Christiana Evers; Nicole Yarab; Veronica Todaro; Lydia Rader; Sheera Rosenfeld
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.